Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.
about
Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseasesMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsHuntington's diseaseQuantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.Rapid quantitative analysis of 8-iso-prostaglandin-F(2alpha) using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method.Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.(1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2.Mechanisms of acute brain injury after subarachnoid hemorrhage.The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosisCannabinoids and neuroinflammation.The effect of caloric restriction and glycemic load on measures of oxidative stress and antioxidants in humans: results from the CALERIE Trial of Human Caloric Restriction.Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's diseaseBiomarkers of Alzheimer disease in plasmaLC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide.Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.Effects of antioxidant supplementation on the aging processIncreased isolevuglandin-modified proteins in glaucomatous astrocytes.Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.Prostaglandins in pathogenesis and treatment of multiple sclerosis.Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes.Editorial: Impact of Lipid Peroxidation on the Physiology and Pathophysiology of Cell Membranes.Effects of polyphenol-rich extract from berries of Aronia melanocarpa on the markers of oxidative stress and blood platelet activation.Kinetic change of oxidative stress in cerebrospinal fluid of mice infected with Angiostrongylus cantonensis.Isoprostenes as indicators of oxidative stress in schizophrenia.Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model.Evaluation of polyphenolic fraction isolated from aerial parts of Tribulus pterocarpus on biological properties of blood platelets in vitro.Oxidative stress in blood platelets from schizophrenic patients.Increased brain levels of F2-isoprostane are an early marker of behavioral sequels in a rat model of global perinatal asphyxia.Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.Minocycline reduces prostaglandin E synthase expression and 8-isoprostane formation in LPS-activated primary rat microglia.
P2860
Q26822872-C983DE98-A22C-4FDE-B023-27DF4E994B8DQ26998412-969587D9-E110-4DA1-A16C-74C947F796E1Q28365461-FD0EB983-951E-497D-A077-D8592929F8F3Q33783345-8AA4CD78-793D-4028-8219-985423137B98Q34018593-32FF5D37-E470-4F97-97F7-0B58D7544CBAQ34046625-7455B1D6-F3BA-4664-B18E-9CEB78D38289Q34172946-6C5E2743-86DF-42A5-A569-D18AE98B9189Q34535638-543592A1-8154-44B3-876D-636CE33EE3E1Q34890688-E409E8D9-1155-4599-BB76-3716C1757BCBQ35046205-4039AE72-EF08-4ACB-9A0E-97BA1BC2D686Q35587913-96138FEC-35F5-4093-BB48-3B32656D7319Q35904286-E4807429-51F7-4FBE-89FB-E02DF05EBD0CQ36045288-8F03B4E1-E9F7-405E-934B-BE808E94144EQ36790461-125C943E-20D0-4ABA-83F0-30C0B2779EFDQ36887316-C1599FCE-65CE-48DA-9C1B-C4105CE33BDAQ37017441-3D29D28B-BD77-4617-AB22-57F354031D93Q37213688-9E4DDD2C-6536-4D95-A26B-DDB687125BA9Q37273675-969A34CA-AC94-428D-8B0A-78AB269E4079Q37710103-C821D77C-4A93-4A77-9664-48FC32343021Q42042951-7A003D8B-A649-4488-BE93-322DA2C3FE9DQ42392514-0FBCA264-6DC0-4E4B-A63F-233229F2BA7AQ43135339-99AEF8B4-4798-4455-85AD-D671420B5BDAQ43144916-DDDF74E4-08A6-4DB9-8517-849635A578DAQ43293458-0723CE0E-8DE7-4911-BD75-862AF76F891AQ43962253-61EFEC45-BBCD-4113-A2E8-1026A3A26A7CQ45813271-A1EBB4BE-0BCA-4148-BD60-ABA3D345CBDDQ46763598-D8DD4EEE-0786-46C2-9B92-D761A815F2DEQ48170843-FB03F692-DACB-4452-AB30-41A38B40BA1CQ53001350-FBF6BE2C-4985-4442-8EF2-6B41EF371720Q54518414-D0FC7D7A-5EDD-4EAE-98AC-A6E5380C56D6
P2860
Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@ast
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@en
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@nl
type
label
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@ast
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@en
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@nl
prefLabel
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@ast
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@en
Isoprostanes, novel markers of ...... of neurodegenerative diseases.
@nl
P356
P1476
Isoprostanes, novel markers of ...... of neurodegenerative diseases
@en
P2093
P2888
P304
P356
10.1023/A:1007608615682
P50
P577
2000-10-01T00:00:00Z
P6179
1047158564